Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply - Letter to the editor: Comment on "Dietary pattern in autism increases the need for probiotic supplementation: A comprehensive narrative and systematic review on oxidative stress hypothesis".
Zarezadeh M, Mahmoudinezhad M, Hosseini B, Khorraminezhad L, Razaghi M, Alvandi E, Saedisomeolia A. Zarezadeh M, et al. Among authors: alvandi e. Clin Nutr. 2024 Jan;43(1):309-310. doi: 10.1016/j.clnu.2023.11.023. Epub 2023 Nov 15. Clin Nutr. 2024. PMID: 37993390 No abstract available.
DHA-enriched fish oil upregulates cyclin-dependent kinase inhibitor 2A (P16INK) expression and downregulates telomerase activity without modulating effects of PPARγ Pro12Ala polymorphism in type 2 diabetic patients: A randomized, double-blind, placebo-controlled clinical trial.
Toupchian O, Sotoudeh G, Mansoori A, Abdollahi S, Ali Keshavarz S, Djalali M, Nasli-Esfahani E, Alvandi E, Chahardoli R, Koohdani F. Toupchian O, et al. Among authors: alvandi e. Clin Nutr. 2018 Feb;37(1):91-98. doi: 10.1016/j.clnu.2016.12.007. Epub 2016 Dec 19. Clin Nutr. 2018. PMID: 28024882 Clinical Trial.
The Effects of Nano-curcumin Supplementation on Leptin and Adiponectin in Migraine Patients: A Double-blind Clinical Trial Study from Gene Expression to Clinical Symptoms.
Sedighiyan M, Jafari E, Athar SS, Yekaninejad MS, Alvandi E, Abdolahi M, Djalali M. Sedighiyan M, et al. Among authors: alvandi e. Endocr Metab Immune Disord Drug Targets. 2023;23(5):711-720. doi: 10.2174/1871530322666220701100817. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 35786344 Clinical Trial.
25 results